Next Generation Sequencing (NGS) Market By Application (Oncology, Clinical Investigation, Reproductive Health, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Agrigenomics & Forensics and HLA Typing/Immune System Monitoring) By Technology (Whole Genome Sequencing, Whole Exome Sequencing and Targeted Sequencing & Resequencing), By End Users (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech): Global Industry Perspective, Comprehensive Analysis Forecasts 2022 - 2030

Global next generation sequencing market size is projected to be worth USD 36 Billion by 2026, expanding at CAGR of 18.2% during the forecast period (2022 - 2030), The market was valued at USD 6.47 Billion in 2021.

The term next generation sequencing (NGS) is an extremely parallel sequencing technology that provides ultra-high throughput, speed, and scalability. It is also identified as "high-throughput sequencing," referring to a range of modern sequencing technologies. This technology is utilized to determine the order of nucleotides in complete genomes or targeted regions of DNA or RNA, and also this technology makes it potential to sequence RNA and DNA in a dependable and cost-effective way. The requirements for next-generation sequencing are increasing overall in medical appliances as they are generally used in functional genomics to test DNA and RNA samples.

Next Generation Sequencing (NGS) Market: Growth Factors

Due to the continuous technological advancements in sequencers, the initiation of convenient, portable, and efficient NGS platforms are allowed that is capable of giving quick and exact outcomes and showing a better turnaround time where major players are mostly focused on the research & development of these products to make stronger their growth positions and revenues. This is driving the NGS market growth worldwide.  Also, the enhancement in genome mapping activities is boosting the global next-generation sequencing market in the near future.  Moreover, the major factors such as declining costs of genome sequencing and rising occurrence of cancer, the expansion in NGS platforms, and the growing usage of next-generation sequencing in cancer research centers are fuelling the market growth in the NGS across the globe.

Importantly, government associations are sequencing millions of genomes for the advancement of research as well as diagnosing and treating cancer disease and other diseases where large sequencing initiatives are likely to offer positive growth opportunities for key companies during the forecast period.

On the other hand, several academic & research institutes are facing budget limitations while purchasing and using advanced and premium-priced equipment and technologies, as academic research & development in emergent countries is usually dependent on external funding. Due to this, the development of advanced research amenities is hindered in the academic and research institutes in emergent countries. This, in turn, is impeding the market globally during the forecast period.

Next Generation Sequencing (NGS) Market: Regional Analysis

North America is leading the global next-generation sequencing market, followed by the European region, due to factors such as the growth in the utilization of next-generation sequencing in genomics research and diagnostics. Also, the launching of the latest products is propelling the market growth in the region.

Furthermore, the Asia-Pacific region is anticipated to have the largest market share in the forthcoming years as a result of the bigger investment by pharma and biotech industries is estimated to increase the user’s demand.

Next Generation Sequencing (NGS) Market: Top Market Players

Various players operating in the next-generation sequencing market cover Genomatix GmbH, Agilent Technology, PierianDx; DNASTAR Inc., Illumina, Eurofins GATC Biotech GmbH, QIAGEN, F. Hoffman-La Roche Ltd., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Bio-Rad Laboratories Inc., BGI Group, and Perkin Elmer Inc.

For example, PierianDx has strengthened its clinical and laboratory facility to effectively diagnose and cure cancer and other chronic diseases. In 2019, the company had raised a $26,870,702 series B round from ATW Partners, RTI International, and SJF Ventures.

Report Attribute Details
The market size value in 2021 USD 36 billion
The revenue forecast in 2030 USD 563 billion
Growth Rate CAGR of 18.2% from 2022 to 2030
The base year for estimation 2021
Historical data 2018 – 2020
Forecast period 2022 – 2030
Top Manufacturers Genomatix GmbH, Agilent Technology, PierianDx; DNASTAR Inc., Illumina, Eurofins GATC Biotech GmbH, QIAGEN, F. Hoffman-La Roche Ltd., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Bio-Rad Laboratories Inc., BGI Group, and Perkin Elmer Inc.
By Application Oncology, Clinical Investigation, Reproductive Health, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring
By Technology Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing, Others
By End-User
Academic Research, Clinical Research,  Hospitals & Clinics, Pharma & Biotech Entities, Other users
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa

This report segments the global next generation sequencing market as follows:

Global Next Generation Sequencing (NGS) Market: By Application

  • Oncology
  • Clinical Investigation
  • Reproductive Health
  • Metagenomics
  • Epidemiology & Drug Development
  • Consumer Genomics
  • Agrigenomics & Forensics
  • HLA Typing/Immune System Monitoring

Global Next Generation Sequencing (NGS) Market: By Technology

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing
  • Others

Global Next Generation Sequencing (NGS) Market: By End-User

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other users

Global Next Generation Sequencing (NGS) Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

1. Preface
                1.1. Study Scope and Description
                1.2. Research Scope
                1.3. Research Methodology
                                1.3.1. Market Research Process
                                1.3.2. Market Research Methodology

2. Executive Summary
                2.1. Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018–2030 (USD Billion)
                2.2. Next Generation Sequencing (NGS) Market: Snapshot

3. Global Next Generation Sequencing (NGS) Market– Industry Analysis
                3.1. Next Generation Sequencing (NGS) Market: Market Growth Factors
                3.2. Market Drivers
                                3.2.1. Technological advancements in next-generation sequencing (NGS) platforms
                                3.2.2. Increase genome mapping activities
                3.3. Market Restraints
                                3.3.1. Restraint 1
                                3.3.2. Restraint 2
                3.4. Market Opportunities
                3.5. Future Trends
                3.6. Porter’s Five Forces Analysis
                3.7. Market Attractiveness Analysis
                                3.7.1. Market attractiveness analysis By Application
                                3.7.2. Market attractiveness analysis By Technology
                                3.7.3. Market attractiveness analysis By End-User
                                3.7.4. Market attractiveness analysis By Region

4. Global Next Generation Sequencing (NGS) Market– Competitive Landscape
                4.1. Company market share analysis
                                4.1.1. Global Next Generation Sequencing (NGS) Market: company market share, 2021
                4.2. Strategic development
                                4.2.1. Mergers & Acquisitions
                                4.2.2. Latest Product launches
                                4.2.3. Partnerships, collaborations, agreements, and joint ventures
                                4.2.4. Research & development and Regional expansion
                4.3. Value trend analysis

5. Global Next Generation Sequencing (NGS) Market Synopsis – Application Analysis
                5.1. Global Next Generation Sequencing (NGS) Market overview: By Application
                                5.1.1. Global Next Generation Sequencing (NGS) Market share, By Application, Revenue and Forecast 2022 and 2030
                5.2. Oncology
                                5.2.1. Global Next Generation Sequencing (NGS) Market by Oncology, Revenue and Forecast 2018–2030 (USD Billion)
                5.3. Clinical Investigation
                                5.3.1. Global Next Generation Sequencing (NGS) Market by Clinical Investigation, Revenue and Forecast 2018–2030 (USD Billion)
                5.4. Reproductive Health
                                5.4.1. Global Next Generation Sequencing (NGS) Market by Reproductive Health, Revenue and Forecast 2018–2030 (USD Billion)
                5.5. Metagenomics
                                5.5.1. Global Next Generation Sequencing (NGS) Market by Metagenomics, Revenue and Forecast 2018–2030 (USD Billion)
                5.6. Epidemiology & Drug Development
                                5.6.1. Global Next Generation Sequencing (NGS) Market by Epidemiology & Drug Development, Revenue and Forecast 2018–2030 (USD Billion)
                5.7. Consumer Genomics
                                5.7.1. Global Next Generation Sequencing (NGS) Market by Consumer Genomics, Revenue and Forecast 2018–2030 (USD Billion)
                5.8. Agrigenomics & Forensics
                                5.8.1. Global Next Generation Sequencing (NGS) Market by Agrigenomics & Forensics, Revenue and Forecast 2018–2030 (USD Billion)
                5.9. HLA Typing/Immune System Monitoring
                                5.9.1. Global Next Generation Sequencing (NGS) Market by HLA Typing/Immune System Monitoring, Revenue and Forecast 2018–2030 (USD Billion)

6. Global Next Generation Sequencing (NGS) Market Synopsis – Technology Analysis
                6.1. Global Next Generation Sequencing (NGS) Market overview: By Technology
                                6.1.1. Global Next Generation Sequencing (NGS) Market share, By Technology, Revenue and Forecast 2022 and 2030
                6.2. Whole Genome Sequencing
                                6.2.1. Global Next Generation Sequencing (NGS) Market by Whole Genome Sequencing, Revenue and Forecast 2018–2030 (USD Billion)
                6.3. Whole Exome Sequencing
                                6.3.1. Global Next Generation Sequencing (NGS) Market by Whole Exome Sequencing, Revenue and Forecast 2018–2030 (USD Billion)
                6.4. Targeted Sequencing & Resequencing
                                6.4.1. Global Next Generation Sequencing (NGS) Market by Targeted Sequencing & Resequencing, Revenue and Forecast 2018–2030 (USD Billion)
                6.5. Others
                                6.5.1. Global Next Generation Sequencing (NGS) Market by Others, Revenue and Forecast 2018–2030 (USD Billion)

7. Global Next Generation Sequencing (NGS) Market Synopsis – End-User Analysis
                7.1. Global Next Generation Sequencing (NGS) Market overview: By End-User
                                7.1.1. Global Next Generation Sequencing (NGS) Market share, By End-User, Revenue and Forecast 2022 and 2030
                7.2. Academic Research
                                7.2.1. Global Next Generation Sequencing (NGS) Market by Academic Research, Revenue and Forecast 2018–2030 (USD Billion)
                7.3. Clinical Research
                                7.3.1. Global Next Generation Sequencing (NGS) Market by Clinical Research, Revenue and Forecast 2018–2030 (USD Billion)
                7.4. Hospitals & Clinics
                                7.4.1. Global Next Generation Sequencing (NGS) Market by Hospitals & Clinics, Revenue and Forecast 2018–2030 (USD Billion)
                7.5. Pharma & Biotech Entities
                                7.5.1. Global Next Generation Sequencing (NGS) Market by Pharma & Biotech Entities, Revenue and Forecast 2018–2030 (USD Billion)
                7.6. Others
                                7.6.1. Global Next Generation Sequencing (NGS) Market by Others, Revenue and Forecast 2018–2030 (USD Billion)

8. Global Next Generation Sequencing (NGS) Market Synopsis - Regional Analysis
                8.1. Global Next Generation Sequencing (NGS) Market overview: by Region
                                8.1.1. Global Next Generation Sequencing (NGS) Market share, by Region, Revenue and Forecast 2022 and 2030
                8.2. North America
                                8.2.1. North America Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018-2030 (USD Billion)
                                8.2.2. North America Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                8.2.3. North America Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                8.2.4. North America Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.2.5. The U.S.
                                                8.2.5.1. The U.S. Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.2.5.2. The U.S. Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.2.5.3. The U.S. Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.2.6. Rest of North America
                                                8.2.6.1. Rest of North America Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.2.6.2. Rest of North America Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.2.6.3. Rest of North America Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                8.3. Europe
                                8.3.1. Europe Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018-2030 (USD Billion)
                                8.3.2. Europe Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                8.3.3. Europe Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                8.3.4. Europe Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.3.5. UK
                                                8.3.5.1. U.K. Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.3.5.2. U.K. Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.3.5.3. U.K. Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.3.6. France
                                                8.3.6.1. France Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.3.6.2. France Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.3.6.3. France Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.3.7. Germany
                                                8.3.7.1. Germany Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.3.7.2. Germany Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.3.7.3. Germany Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.3.8. Rest of Europe
                                                8.3.8.1. Rest of Europe Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.3.8.2. Rest of Europe Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.3.8.3. Rest of Europe Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                8.4. Asia Pacific
                                8.4.1. Asia Pacific Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018-2030 (USD Billion)
                                8.4.2. Asia Pacific Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                8.4.3. Asia Pacific Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                8.4.4. Asia Pacific Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.4.5. China
                                                8.4.5.1. China Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.4.5.2. China Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.4.5.3. China Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.4.6. Japan
                                                8.4.6.1. Japan Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.4.6.2. Japan Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.4.6.3. Japan Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.4.7. India
                                                8.4.7.1. India Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.4.7.2. India Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.4.7.3. India Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.4.8. Rest of Asia Pacific
                                                8.4.8.1. Rest of Asia Pacific Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.4.8.2. Rest of Asia Pacific Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.4.8.3. Rest of Asia Pacific Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                8.5. Latin America
                                8.5.1. Latin America Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018-2030 (USD Billion)
                                8.5.2. Latin America Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                8.5.3. Latin America Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                8.5.4. Latin America Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.5.5. Brazil
                                                8.5.5.1. Brazil Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.5.5.2. Brazil Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.5.5.3. Brazil Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.5.6. Rest of Latin America
                                                8.5.6.1. Rest of Latin America Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.5.6.2. Rest of Latin America Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                                8.5.6.3. Rest of Latin America Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                8.6. The Middle East and Africa
                                8.6.1. The Middle East and Africa Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.2. The Middle East and Africa Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.3. The Middle East and Africa Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.4. The Middle East and Africa Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.5. Saudi Arabia Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.6. Saudi Arabia Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.7. Saudi Arabia Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.8. UAE Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.9. UAE Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.10. UAE Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.11. The Rest of Middle East and Africa Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.12. The Rest of Middle East and Africa Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018-2030 (USD Billion)
                                8.6.13. The Rest of Middle East and Africa Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018-2030 (USD Billion)

9. Company Profiles
                9.1. Genomatix GmbH
                                9.1.1. Overview
                                9.1.2. Financials Synopsis
                                9.1.3. Product Portfolio
                                9.1.4. Business Tactic
                                9.1.5. Key Developments
                9.2. Agilent Technology
                                9.2.1. Overview
                                9.2.2. Financials Synopsis
                                9.2.3. Product Portfolio
                                9.2.4. Business Tactic
                                9.2.5. Key Developments
                9.3. PierianDx
                                9.3.1. Overview
                                9.3.2. Financials Synopsis
                                9.3.3. Product Portfolio
                                9.3.4. Business Tactic
                                9.3.5. Key Developments
                9.4. DNASTAR Inc.
                                9.4.1. Overview
                                9.4.2. Financials Synopsis
                                9.4.3. ProductPortfolio
                                9.4.4. Business Tactic
                                9.4.5. Key Developments
                9.5. Illumina
                                9.5.1. Overview
                                9.5.2. Financials Synopsis
                                9.5.3. Product Portfolio
                                9.5.4. Business Tactic
                                9.5.5. Key Developments
                9.6. Eurofins GATC Biotech GmbH
                                9.6.1. Overview
                                9.6.2. Financials Synopsis
                                9.6.3. Product Portfolio
                                9.6.4. Business Tactic
                                9.6.5. Key Developments
                9.7. QIAGEN
                                9.7.1. Overview
                                9.7.2. Financials Synopsis
                                9.7.3. Product Portfolio
                                9.7.4. Business Tactic
                                9.7.5. Key Developments
                9.8. F. Hoffman-La Roche Ltd.
                                9.8.1. Overview
                                9.8.2. Financials Synopsis
                                9.8.3. Product Portfolio
                                9.8.4. Business Tactic
                                9.8.5. Key Developments
                9.9. Thermo Fisher Scientific Inc.
                                9.9.1. Overview
                                9.9.2. Financials Synopsis
                                9.9.3. Product Portfolio
                                9.9.4. Business Tactic
                                9.9.5. Key Developments
                9.10. Oxford Nanopore Technologies
                                9.10.1. Overview
                                9.10.2. Financials Synopsis
                                9.10.3. Product Portfolio
                                9.10.4. Business Tactic
                                9.10.5. Key Developments
                9.11. Bio-Rad Laboratories Inc.
                                9.11.1. Overview
                                9.11.2. Financials Synopsis
                                9.11.3. Product Portfolio
                                9.11.4. Business Tactic
                                9.11.5. Key Developments
                9.12. BGI Group
                                9.12.1. Overview
                                9.12.2. Financials Synopsis
                                9.12.3. Product Portfolio
                                9.12.4. Business Tactic
                                9.12.5. Key Developments
                9.13. Perkin Elmer Inc.
                                9.13.1. Overview
                                9.13.2. Financials Synopsis
                                9.13.3. Product Portfolio
                                9.13.4. Business Tactic
                                9.13.5. Key Developments

10. Appendix

List of Figures

1. Market Research Overview

2. Market Research Methodology

3. Global Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018–2030 (USD Billion)

4. Porter’s Five Forces Analysis

5. Global Next Generation Sequencing (NGS) Market Attractiveness, By Application

6. Global Next Generation Sequencing (NGS) Market Attractiveness, By Technology

7. Global Next Generation Sequencing (NGS) Market Attractiveness, By End-User

8. Global Next Generation Sequencing (NGS) Market share by Application, Revenue and Forecast 2022 and 2030(USD Billion)

9. Global Next Generation Sequencing (NGS) Market by Oncology, Revenue and Forecast 2018–2030 (USD Billion)

10. Global Next Generation Sequencing (NGS) Market by Clinical Investigation, Revenue and Forecast 2018–2030 (USD Billion)

11. Global Next Generation Sequencing (NGS) Market by Reproductive Health, Revenue and Forecast 2018–2030 (USD Billion)

12. Global Next Generation Sequencing (NGS) Market by Metagenomics, Revenue and Forecast 2018–2030 (USD Billion)

13. Global Next Generation Sequencing (NGS) Market by Epidemiology & Drug Development, Revenue and Forecast 2018–2030 (USD Billion)

14. Global Next Generation Sequencing (NGS) Market by Consumer Genomics, Revenue and Forecast 2018–2030 (USD Billion)

15. Global Next Generation Sequencing (NGS) Market by Agrigenomics & Forensics, Revenue and Forecast 2018–2030 (USD Billion)

16. Global Next Generation Sequencing (NGS) Market by HLA Typing/Immune System Monitoring, Revenue and Forecast 2018–2030 (USD Billion)

17. Global Next Generation Sequencing (NGS) Market share by Technology, Revenue and Forecast 2022 and 2030(USD Billion)

18. Global Next Generation Sequencing (NGS) Market by Whole Genome Sequencing,Revenue and Forecast 2018–2030 (USD Billion)

19. Global Next Generation Sequencing (NGS) Market by Whole Exome Sequencing, Revenue and Forecast 2018–2030 (USD Billion)

20. Global Next Generation Sequencing (NGS) Market by Targeted Sequencing & Resequencing, Revenue and Forecast 2018–2030 (USD Billion)

21. Global Next Generation Sequencing (NGS) Market by Others, Revenue and Forecast 2018–2030 (USD Billion)

22. Global Next Generation Sequencing (NGS) Market share by End-User, Revenue and Forecast 2022 and 2030(USD Billion)

23. Global Next Generation Sequencing (NGS) Market by Academic Research,Revenue and Forecast 2018–2030 (USD Billion)

24. Global Next Generation Sequencing (NGS) Market by Clinical Research, Revenue and Forecast 2018–2030 (USD Billion)

25. Global Next Generation Sequencing (NGS) Market by Hospitals & Clinics, Revenue and Forecast 2018–2030 (USD Billion)

26. Global Next Generation Sequencing (NGS) Market by Pharma & Biotech Entities, Revenue and Forecast 2018–2030 (USD Billion)

27. Global Next Generation Sequencing (NGS) Market by Others, Revenue and Forecast 2018–2030 (USD Billion)

28. Global Next Generation Sequencing (NGS) Market share, by Region, Revenue and Forecast 2022 and 2030

29. North America Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018–2030 (USD Billion)

30. Europe Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018–2030 (USD Billion)

31. Asia Pacific Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018–2030 (USD Billion)

32. Latin America Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018–2030 (USD Billion)

33. The Middle East and Africa Next Generation Sequencing (NGS) Market, Revenue and Forecast 2018–2030 (USD Billion)

List of Tables

1. Global Next Generation Sequencing (NGS) Market: snapshot

2. Drivers of the Next Generation Sequencing (NGS) Market: impact analysis

3. North America Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

4. North America Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

5. North America Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

6. The U.S. Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

7. The U.S. Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

8. The U.S. Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

9. Rest of North America Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

10. Rest of North America Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

11. Rest of North America Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

12. Europe Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

13. Europe Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

14. Europe Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

15. UK Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

16. UK Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

17. UK Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

18. France Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

19. France Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

20. France Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

21. Germany Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

22. Germany Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

23. Germany Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

24. Rest of Europe Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

25. Rest of Europe Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

26. Rest of Europe Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

27. Asia Pacific Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

28. Asia Pacific Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

29. Asia Pacific Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

30. China Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

31. China Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

32. China Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

33. Japan Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

34. Japan Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

35. Japan Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

36. India Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

37. India Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

38. India Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

39. Rest of Asia Pacific Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

40. Rest of Asia Pacific Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

41. Rest of Asia Pacific Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

42. Latin America Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

43. Latin America Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

44. Latin America Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

45. Brazil Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

46. Brazil Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

47. Brazil Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

48. Rest of Latin America Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

49. Rest of LatinAmerica Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

50. Rest of LatinAmerica Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

51. The Middle East and Africa Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

52. The Middle East and Africa Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

53. The Middle East and Africa Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

54. Saudi Arabia Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

55. Saudi Arabia Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

56. Saudi Arabia Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

57. South Africa Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

58. South Africa Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

59. South Africa Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

60. Rest of the Middle East & Africa Next Generation Sequencing (NGS) Market, By Application, Revenue and Forecast 2018–2030 (USD Billion)

61. Rest of the Middle East & Africa Next Generation Sequencing (NGS) Market, By Technology, Revenue and Forecast 2018–2030 (USD Billion)

62. Rest of the Middle East & Africa Next Generation Sequencing (NGS) Market, By End-User, Revenue and Forecast 2018–2030 (USD Billion)

Research Framework

Vertex Market Research presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources
  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers
Secondary sources
  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis
  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights
Data Validation
  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative
  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis
Quantitative
  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Frequently Asked Questions About This Report

Some of the major drivers of the next-generation sequencing market include advancements in NGS platforms, declining costs of genome sequencing, and improving regulatory and reimbursement scenario for NGS-based diagnostic tests.

The global NGS market size was estimated at USD 4.0 billion in 2020 and is expected to reach USD 4.4 billion in 2021.

Genomatix GmbH, Agilent Technology, PierianDx; DNASTAR Inc., Illumina, Eurofins GATC Biotech GmbH, QIAGEN, F. Hoffman-La Roche Ltd., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Bio-Rad Laboratories Inc., BGI Group, and Perkin Elmer Inc.

North America dominated the NGS market with a share of 47.2% in 2019. This is attributable to the presence of major clinical laboratories that are using next-generation sequencing technology to perform genetic tests.

The key trends in the next generation sequence market are due to rise in technological advancements, especially nanopore sequencing in NGS and rise in the need to improve diagnostic procedures and ensure quality treatment is boosting the growth of next generation sequencing market.

Up